Connect with us

Life Sciences

Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application

Know Labs,, an emerging developer of non-invasive medical diagnostic technology,shared an update on its strategic partnerships with leading experts in…

Published

on

This article was originally published by AITHORITY
Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook

Know Labs,, an emerging developer of non-invasive medical diagnostic technology,shared an update on its strategic partnerships with leading experts in data science, sensor technology, product design and regulatory affairs. These strategic partners collectively accelerate Know Labs’ progress toward the FDA clearance process for the world’s first non-invasive glucose monitoring medical devices.

“Doing something that’s never been done before not only takes time and thoughtful attention to detail – it takes industry experts with high levels of experience and expertise,” said Ron Erickson, CEO and Chairman at Know Labs. “We are fortunate to have world-class respected experts working alongside our own talented Know Labs team, to help accelerate our progress on data science, product design and the regulatory process, as we develop medical devices that we believe will transform patient care.”

Recommended AI News: cQuant.io and Hartigen Announce Partnership for Portfolio Optimization & Analytics

With 30 years in medical device and high-tech design and development, Dr. Reza Kassayan, MD, BSEE has been lead designer and system architect for numerous commercially successful large-scale projects. He specializes in ultra-miniaturized embedded electronics for medical devices and has been assisting the Know Labs team to further refine Know Labs’ Bio-RFID sensor. “It’s inspiring to see the potential impact for this novel application of radio frequency spectroscopy. Having engineered other life-changing non-invasive medical devices, I’m thrilled to be supporting this development,” Kassayan said.

Igor Institute, a product development firm specializing in mechanical, electrical, and firmware engineering known for its work with multiple consumer brands, has been working with Know Labs since 2018 on Bio-RFID sensor development and optimization. Igor works closely with Know Labs’ engineering team and is a foundational partner of high importance to the platform. Aren Kaser, Co-Founder and CEO of Igor Institute shared, “It is in our DNA to support hardware development from early stage inception to taking the most complex products to-market, and it’s been incredible to aim our expertise in mechanical, electrical, and firmware engineering to support the development of the first functioning prototype of the Know Labs non-invasive glucose monitor.”

The respected industrial design firm behind successful products such as Nest Roku and Willow Bould Design has been providing Know Labs with design support on an updated prototype of Know Labs’ non-invasive glucose monitoring medical devices. “With function at the core of our design principles, we’re excited to help design a first-of-its-kind medical device with the potential to improve so many people’s lives,” said Fred Bould, Principal Partner and Design Director, Bould Design.

Recommended AI News: SQream Announces Industry-First 60 Day Proof of Value to Demonstrate Business Results with Panoply

Edge Impulse, the industry-leading development toolkit for machine learning, is collaborating with Know Labs to accelerate Bio-RFID’s algorithm refinement, an essential step for interpreting its existing robust data set and ultimately supporting large-scale clinical trials. Edge Impulse has partnered with companies in similar stages of development across a variety of fields in health, health wearable technology, agriculture and infrastructure. “We’ve spent the last six months working alongside Know Labs’ software team to accelerate algorithm development for their non-invasive glucose monitor and are reminded each day how incredible it is to demonstrate algorithm performance in such novel data,” said Zach Shelby, co-founder and CEO of Edge Impulse.

A medical device consulting firm, NOVUS Management Group LLC, has been providing regulatory systems and strategy guidance to Know Labs to prepare the company for the FDA clearance process. Novus has supported the application and approval of more than 30 products through the FDA.

Recommended AI News: Third Coast Bank Chooses Klarivis to Boost Customer Experience

[To share your insights with us, please write to sghosh@martechseries.com]

The post Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application appeared first on AiThority.

spectroscopy





devices

machine learning


clinical trials

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending